Get started
ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

LLY trade ideas

ELI LILLY Approaching the top of the Channel. Sell opportunity.Last time we looked at Eli Lilly and Company (LLY) was on March 01 (see chart below) where we called for the most optimal buy entry exactly at the bottom of the bullish pattern: The price is now approaching the top of the 3 year logarithmic Channel Up, highly overbought with the RSI on the 1W time-frame at 80.00. This gradually calls for a sell towards the end of August, targeting the 1D MA100 (red trend-line) at $480.00, where the stock will turn into a buy opportunity again. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:LLYShort
by TradingShot
1
LLY Earnings Play LONG ( Flat Bottom Triangle Breakout)My analysis is on the 2H. I am uniquely qualified in my fundamental analysis. This is a one day until earnings. My thesis is the earnings will stimulate what will be a breakout from a flat bottom triangle. I will buy one share of stock. I will spend a similar amount on call options striking $460 expiring August 11th. I see LLY as surging while PFE is a bit challenged with the fall off in Covid vaccine work. If you find this idea interesting and might appreciate my ideas as to a stop loss and targets, leave a comment. Like and subscribe. Trade well !
NYSE:LLYLong
by AwesomeAvani
1
LDMR (Long Derivative Mean Reversion)(LDMR)Long Derivative Mean Reversion is primarily a tool for measuring risk and capital efficiency. It's secondary functions include identify outliers in the assignment value of derivatives, maintaining a price target and producing trade placement recommendations. This strategy has one simple input: the symbol of a correlated asset or index. It is recommended to use leveraged indexes in this input because they have a higher derivative correlation with those of round lots of the underlying. When using this strategy you should always adjust the initial capital to what it will cost you to control 100 shares of the security. If you intend to purchase shares then that value is 100x the close price. if you intend to purchase call options to resell for premiums you use the initial premiums paid for the calculation. If you intend to create a synthetic position you should add all deployed capital together, and that calculation will remain accurate until the max profit limit of your short option is reached. Pyramiding is supported for trade placement. You should always review the historical depth and before placing the first trade ensure you have enough capital to cover the largest of those positions. Otherwise your results may be entirely incomparable to the risk and capital efficiency estimates the tool provides. Let me know what you think. I am considering a private publishing and want to know what this is worth!
NYSE:LLY
by KYLEFLYNN
Eli Lilly Finally Pulls BackDrug developer Eli Lilly shot to new highs earlier in the year, and now it’s finally pulled back. The first pattern on today’s chart is the high-volume bullish candle on May 3. The move followed positive Phase 3 data for donanemab, its potential Alzheimer's disease treatment. Second, prices are trying to hold the rising 21-day exponential moving average. That may indicate its short-term uptrend remains in effect. Third, LLY apparently got ahead of itself last week and was unable to hold a new all-time high. But its quick pullback dragged stochastics to an oversold level where some buyers may feel more comfortable with the risk/reward. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
Editors' picks
NYSE:LLY
by TradeStation
5
LLY - Sell the Good News??As compelling as the recent drug breakthrough may have been, it seems to have opened up an opportunity - time to short LLY stock? Healthcare has shown a lot of strength in general this year, but has lately shown it can move independently of the market. For instance, during the August rally, it declined significantly. However, in this September slowdown, it has instead consolidated at nearly the same price level. You could view a short on this stock as a hedge to whatever you may be doing with the index. LLY in general has been overvalued for a while, especially comparing to other healthcare stocks and even when accounting for future growth. However, a number of strong supports have formed as the stock has gone higher. I think that a cautious short position would be good here, but pay close attention to the $320 and $300 level. It looks like it has rejected anything higher than the current levels (see bearish top wick & previous triple top.) There could be some news risk.
NYSE:LLYShort
by roxythetradermage
LLY - Rising Trend Channel [Mid Term]- LLY is in a rising trend channel in the medium long term. - LLY has also received a positive signal from the moving average indicator, thus signaling a continued rise. - LLY has broken up through resistance at 375. - The short term momentum of the stock is strongly positive, with RSI above 70. - Overall assessed as technically positive for the medium long term. *EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price *Chart Pattern: DT - Double Top | BEARISH | RED DB - Double Bottom | BULLISH | GREEN HNS - Head & Shoulder | BEARISH | RED REC - Rectangle | BLUE iHNS - inverse head & Shoulder | BULLISH | GREEN Verify it first and believe later. WavePoint ❤️
NYSE:LLYLong
by wavepoint99
LLY - How to handle earningsNYSE:LLY reports this Thursday. The drop in early March to test the bottom of the uptrend was a great opportunity. Now it's at all time high, showing bearish divergence, and has a history of price reversals after earnings releases. I'll be looking for updates on their pipeline management, monjaro production and growth, and progress toward Alzheimer treatment. The latter is high potential, but clinical trials in that space fail regularly. I'll likely take a little profit before earnings and then re-accumulate to pullbacks to the HKEX:347 -356 range.
NYSE:LLY
by Ben_1148x2
OVERBOUGHTRSI is at 82.17. THIS IS NOT TO LONG ENTRY LEVEL. (EL) It is often important to Wait for EL especially when price is struggling. Price is trying to touch the top of the cup. There is not a well formed handle but I drew a green line where I see some support. You may see this differently. ATH is 384.44. Spinning top representing indecision at resistance. No recommendation Price is above the .236 of the trend up. Overbought refers to a security with a price that's higher than its intrinsic value. Many investors use price-earnings (P/E) ratios to determine if a stock is overbought, while traders use technical indicators, like the relative strength index (RSI). An oversold market is one that has fallen sharply and is expected to bounce higher. On the other hand, an overbought market has risen sharply and is possibly ripe for a decline. Securities can remain overbought or oversold for extended periods of time.
NYSE:LLY
by lauralea